# DiaMedica Therapeutics Inc.: Form DEF 14A, filed Jun 3, 2021

- Company: [DiaMedica Therapeutics Inc.](/companies/dmac.md) (CIK 1401040)
- Form: DEF 14A
- Filed: 2021-06-03
- Accepted by EDGAR: Jun 3, 2021, 16:15 ET
- Period: 2021-07-15
- Accession: 0001437749-21-014066
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1401040/000143774921014066/dmtp20210406_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1401040/000143774921014066/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1401040/000143774921014066/dmtp20210406_def14a.htm

Filed Jun 3, 2021.
Source: SEC EDGAR, the filing index for accession 0001437749-21-014066. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.